Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade [Yahoo! Finance]
Inspire Medical Systems, Inc. (NYSE: INSP) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $255.00 price target on the stock, up previously from $220.00.
Inspire Medical Systems, Inc. to Present at Piper Sandler 36th Annual Healthcare Conference
UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
Upper Airway Stimulation Market is Projected to Reach a US$ 2,050.6 Million with 12.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]